Technological and social innovation: A unifying new paradigm for global health

Health Affairs

Volumn 26, Issue 4, 2007, Pages 1052-1061

  Gardner, Charles A ^a   Acharya, Tara ^a   Yach, Derek ^b  

^a ROCKEFELLER FOUNDATION   (United States)

^b PEPSICO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; DEVELOPING COUNTRY; ECONOMICS; EDUCATION; FINANCIAL MANAGEMENT; HEALTH; HEALTH CARE POLICY; HEALTH SERVICES RESEARCH; HUMAN; INTERNATIONAL COOPERATION; LEADERSHIP; MASS COMMUNICATION; MEDICAL TECHNOLOGY; ORGANIZATION AND MANAGEMENT; REVIEW;

BIOMEDICAL TECHNOLOGY; DEVELOPING COUNTRIES; DIFFUSION OF INNOVATION; EDUCATION, DISTANCE; FINANCING, ORGANIZED; HEALTH POLICY; HEALTH SERVICES RESEARCH; HUMANS; INTERNATIONAL COOPERATION; LEADERSHIP; PRIVATE SECTOR; PUBLIC SECTOR; TECHNOLOGY ASSESSMENT, BIOMEDICAL; WORLD HEALTH;

EID: 34548314485     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.26.4.1052     Document Type: Review

References (81)

1. D. Szmytkowski, "Innovation Definition Comparative Assessment," 18 July 2005, http://www.interecho.com/~smith/daniel/resources/ paper_innovation.pdf (accessed 31 January 2007).
2. See R. Widdus and K. White, Combating Diseases Associated with Poverty: Financing Strategies for Product Development and the Potential Role of Public-Private Partnerships, August 2004, http://www.globalforumhealth.org/ filesupld/ippph/CombatingDiseases.pdf (accessed 5 April 2007).
3. We are indebted to Chris Earl of BIOVentures for Global Health (BVGH) for suggesting these terms.
4. J.S. Metcalfe and I. Miles, Innovation Systems in the Service Economy: Measurement and Case Study Analysis (Manchester, U.K.: Kluwer Academic Publishers, 1999);
5. and "The World's Most Innovative Companies," Business Week, 24 April 2006, http://www.businessweek.com/magazine/content/06_17/ b3981401.htm (accessed 31 January 2007).
6. Concepts in this section were first discussed in C. Morel et al., "Health Innovation in Developing Countries to Address Diseases of the Poor," Innovation Strategy Today 1, no. 1 (2005): 1-14;
7. and C.M. Morel et al., "Health Innovation Networks to Help Developing Countries Address Neglected Diseases," Science 309, no. 5733 (2005): 401-404.
8. See online Exhibit 1 at http://content.healthaffairs.org/cgi/content/ full/26/4/1052/DC1.
9. Rockefeller Foundation, Partnering to Develop New Products for Diseases of Poverty (New York: Rockefeller Foundation, 2004);
10. and Widdus and White, Combating Diseases.
11. See, for example, R. Levine, M. Kremer, and A. Albright, Making Markets for Vaccines: Ideas to Action, 2004, pp. 18-26, http://www.cgdev. org/doc/books/vaccine/MakingMarkets-complete.pdf (accessed 5 April 2007).
12. A. Farlow et al., "Concerns regarding the Center for Global Development Report 'Making Markets for Vaccines'," 29 April 2005, http://www.who.int/intellectualproperty/submissions/Vaccines.FarlowLight.pdf (accessed 31 January 2007).
13. M. Moran, "A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need," PLoS Medicine 2, no. 9 (2005): e302.
14. International AIDS Vaccine Initiative, "Advance Market Commitments: Helping to Accelerate AIDS Vaccine Development," Policy Brief (New York: IAVI, 2005);
15. Malaria Vaccine Initiative, "Advance Market Commitments: Helping to Accelerate AIDS Vaccine Development," Policy Brief, November 2005, http://www.iavi.org/viewfile.cfm?fid=35155 (accessed 5 April 2007);
16. and MVI, "Advance Market Commitments Will Accelerate Worldwide Access," http://www.malariavaccine.org/files/AMCstatement2-10-07.htm (accessed 5 April 2007)
17. Here we stretch the definition of implementation research to include research on promoting availability in addition to "that subset of health systems research that focuses on how to promote the uptake and successful implementation of evidence-based interventions and policies." D. Sanders and A. Haines, "Implementation Research Is Needed to Achieve International Health Goals," PLoS Medicine 3, no. 6 (2006): e186.
18. See R. Saha, K. Satyanarayana, and C.A. Gardner, "Building a 'Cottage Industry' for Health (and Wealth): The New Framework for IP Management in India," IP Strategy Today no. 10-2004 (2004): 26-60, http://www.biodevelopments.org/ip/ipst10.pdf (accessed 5 April 2007);
19. Morel et al., "Health Innovation in Developing Countries";
20. Morel et al., "Health Innovation Networks";
21. and H. Thorsteinsdóttir et al., "Health Biotechnology Innovation in Developing Countries," Nature Biotechnology 22 Supp. (2004): DC48-DC52.
22. S. Pefile et al., "Innovation in Developing Countries to Meet Health Needs: Experiences of Brazil, China, South Africa, and India," April 2005, http://www.who.int/intellectualproperty/studies/developing_innovative_capacity/ en/index.html (accessed 5 April 2007).
23. D. Jamison, M.E. Sandbu, and J. Wang, Why Has Infant Mortality Decreased at Such Different Rates in Different Countries? 6 February 2004, http://www.dcp2.org/file/36/wp21.pdf (accessed 5 April 2007).
24. Global Forum for Health Research, Monitoring Financial Flows for Health Research, vol. 2 (Geneva: GFHR, 2004), 14-15.
25. J. Coloma and E. Harris, "Innovative Low Cost Technologies for Biomedical Research and Diagnosis in Developing Countries," British Medical Journal 329, no. 7475 (2004): 1160-1162;
26. and Goldman Sachs Global Investment Research, "Global Healthcare: Indian Pharmaceuticals" (New York: Goldman Sachs, 7 April 2005).
27. Goldman Sachs, "Global Healthcare";
28. and Frost and Sullivan Research Service, "Advantages and Disadvantages of Increasing Pharmaceutical R&D Outsourcing to India and China," 22 July 2005, http://www.frost.com/prod/servlet/report-brochure. pag?id=B600-01-00-00-00 (accessed 31 January 2007).
29. D.A. King, "The Scientific Impact of Nations," Nature 430, no. 6997 (2004): 311-316;
30. and Morel et al., "Health Innovation Networks."
31. Morel et al., "Health Innovation in Developing Countries."
32. Thorsteinsdóttir et al., "Health Biotechnology Innovation in Developing Countries."
33. To varying degrees, advanced developing countries have begun to address these problems. See, for example, Saha et al., "Building a 'Cottage Industry'";
34. and M.P. Ryan, "Brazil's Quiet Bio-Medical Innovation Revolution: Drugs, Patents, and the '10/90 Health Research Gap'," 2006, http://www.law.gwu.edu/NR/rdonlyres/A4C5FD97-7A82-4793-BEE9-A9ADA1EFB117/0/ CIEC_Brazil_study.pdf (accessed 31 January 2007).
35. Goldman Sachs, "Global Healthcare."
36. H.E. Bale Jr., "Consumption and Trade in Off-Patented Medicines," May 2001, http://www.cmhealth.org/docs/wg4_paper3.pdf (accessed 5 April 2007).
37. C. Grace, The Effect of Changing Intellectual Property on Pharmaceutical Industry Prospects in India and China: Considerations for Access to Medicines, June 2004, http://www.dfid.gov.uk/pubs/files/ indiachinadomproduce.pdf (accessed 5 April 2007).
38. Thorsteinsdóttir et al., "Health Biotechnology Innovation in Developing Countries."
39. Program for Appropriate Technology in Health, "Historic Protection for Asia's Children," 2006, http://www.path.org/projects/ japanese_encephalitis_project.php (accessed 31 January 2007).
40. L. Herrera, "Developing Country Vaccine Manufacturing Network," June 2001, http://www.vaccinealliance.org/resources/herrera.ppt (accessed 5 April 2007).
41. H. Kettler and R. Modi, "Building Local Research and Development Capacity for the Prevention and Cure of Neglected Diseases: The Case of India," Bulletin of the World Health Organization 79, no. 8 (2001): 742-747;
42. Pefile et al., "Innovation in Developing Countries";
43. Grace, "The Effect of Changing Intellectual Property";
44. S. Chaudhuri, "R&D for Development of New Drugs for Neglected Diseases: How Can India Contribute?" 31 March 2005, http://www.who.int/ intellectualproperty/studies/S.%20Chaudhuri.pdf (accessed 5 April 2007);
45. and P.G. Sampath, Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Industry, http://www.who.int/intellectualproperty/studies/ PadmashreeSampathFinal.pdf (accessed 5 April 2007).
46. See online Exhibit 1, as in Note 6.
47. See reports and statements from the 16-20 November 2004 Global Forum for Health Research (GFHR-8) and the WHO Ministerial Summit on Health Research in Mexico City, online at http://www.globalforumhealth.org/Forum8/Statement.html and http://www.who.int/rpc/summit/en, respectively (both accessed 31 January 2007).
48. Also see Sanders and Haines, "Implementation Research Is Needed."
49. B. Oyelaran-Oyeyinka, "Innovation Policies and Practices in Developing Countries: A Methodological Framework" (Ottawa: International Development Research Centre, April 2006);
50. and R. Nelson et al., "A Program of Study of the Processes Involved in Technological and Economic Catchup" (Unpublished paper, Catchup Network, 2005).
51. Richard Nelson, Columbia University, personal communication, February 2006.
52. See online Exhibit 2, as in Note 6.
53. R. Levine et al., Millions Saved: Proven Successes in Global Health (Washington: Center for Global Development, 2004).
54. Ruth Levine, Center for Global Development, personal communication, March 2006.
55. R. Mahoney and C. Morel, "A Global Health Innovation System (GHIS)," Innovation Strategy Today 2, no. 1 (2006): 1-12.
56. R. Laxminarayan et al., "Advancement of Global Health: Key Messages from the Disease Control Priorities Project," Lancet 367, no. 9517 (2006): 1193-1208.
57. T. Pang, M.A. Lansang, and A. Haines, "Brain Drain and Health Professionals," British Medical Journal 324, no. 7336 (2002): 499-500.
58. See, for example, George Foundation, "Health Projects," http://www.tgfworld.org/edps2000.html (accessed 5 April 2007).
59. C.K. Prahalad, University of Michigan, personal communication, November 2005, based on Prahalad, "Building Ecosystems for Breakthrough Innovation: Healthcare Delivery Systems in India" (draft).
60. C. Kapp, "Ernest Darkoh: Confronting the Challenge of HIV/AIDS in Africa," Lancet 368, no. 9534 (2006): 444.
61. See the CFW Shops home page, at http://www.cfwshops.org.
62. B-Å. Lundvall, ed., National Innovation Systems: Towards a Theory of Innovation and Interactive Learning (London: Pinter Publishers, 1992);
63. R. Nelson, ed., National Innovation Systems: A Comparative Analysis (New York: Oxford University Press, 1993);
64. Organization for Economic Cooperation and Development, National Innovation Systems, 1997, http://www.oecd.org/dataoecd/35/56/2101733.pdf (accessed 31 January 2007);
65. and Mahoney and Morel, "A Global Health Innovation System."
66. United Nations, Office of the Special Adviser on Africa, South-South Cooperation in Support of the New Partnership for Africa's Development: Experiences of Africa-Latin America and the Caribbean, 2004, http://www.un.org/esa/africa/South%20South.pdf (accessed 5 April 2007).
67. Carlos Morel, Oswaldo Cruz Foundation, personal communication, April 2006.
68. Ibid.
69. CSIR, "Tshwane Consensus on Science and Development," 19 October 2005, http://www.csir.co.za/plsql/ptl0002/PTL0002_PGE013_MEDIA_REL? MEDIA_RELEASE_NO=7323626 (accessed 31 January 2007).
70. National Science Board, Science and Engineering Indicators 2006, Appendix table 6-17, p. 2, http://www.nsf.gov/statistics/seind06/append/c6/at06- 17.pdf (accessed 31 January 2007).
71. A.L. Brewster, A.R. Chapman, and S.A. Hansen, "Facilitating Humanitarian Access to Pharmaceutical and Agricultural Innovation," Innovation Strategy Today 1, no. 3 (2005): 203-216.
72. U.K. Commission on Intellectual Property Rights, Integrating Intellectual Property Rights and Development Policy, p. 125, September 2002, http://www.iprcommission.org/papers/pdfs/final_report/CIPRfullfinal.pdf (accessed 31 January 2007);
73. and WHO Commission on Intellectual Property Rights, Innovation, and Public Health, Public Health: Innovation and Intellectual Property Rights, 2006, pp. 150-151, http://www.who.int/intellectualproperty/ documents/thereport/ENPublicHealthReport.pdf (accessed 5 April 2007).
74. See the MIHR home page, http://www.mihr.org.
75. P. Gottret and G. Scheiber, Health Financing Revisited: A Practitioner's Guide, 2006, pp. 12, 124, and 133-134, http://siteresources. worldbank.org/INTHSD/Resources/topics/Health-Financing/HFRFull.pdf (accessed 5 April 2007).
76. OECD, "Recent Trends in Official Development Assistance to Health," September 2000, http://www.cmhealth.org/docs/oda_to_health.pdf (accessed 31 January 2007);
77. and M.A. Gonzalez Block and A. Mills, "Assessing Capacity for Health Policy and Systems Research in Low and Middle Income Countries," Health Research Policy and Systems 1, no. 1 (2003): 1.
78. CIPIH, Public Health, 150.
79. Morel et al., "Health Innovation in Developing Countries."
80. T. Godal, "Do We Have the Architecture for Health Aid Right? Increasing Global Aid Effectiveness," Nature Reviews: Microbiology 3, no. 11 (2005): 899-903;
81. and J. Cohen, "The New World of Global Health," Science 311, no. 5758 (2006): 162.